日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1

双磷酸核苷酸酶 1 通过 STUB1 介导的 LIMA1 不稳定化促进三阴性乳腺癌的进展和多西他赛耐药性。

Ling, Yun-Xiao; Andriani, Lisa; Yang, Shao-Ying; Zhao, Qian; Huang, Min-Ying; Zhang, Yin-Ling; Zhang, Fang-Lin; Shao, Zhi-Min; Li, Da-Qiang; Liu, Guang-Yu

MYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast Cancer.

MYC/TET3 调控的 TMEM65 激活 OXPHOS-SERPINB3 通路,促进三阴性乳腺癌的进展和顺铂耐药性。

Zhang Yin-Ling, Huang Min-Ying, Yang Shao-Ying, Cai Jia-Yang, Zhao Qian, Zhang Fang-Lin, Hu Xin, Shao Zhi-Min, Liao Li, Cao A-Yong, Li Da-Qiang

Secernin-2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple-Negative Breast Cancer.

Secernin-2 可稳定组蛋白甲基转移酶 KMT2C,从而抑制三阴性乳腺癌的进展并赋予其对 PARP 抑制剂的治疗敏感性

Huang Min-Ying, Cai Jia-Yang, Yang Shao-Ying, Zhao Qian, Shao Zhi-Min, Zhang Fang-Lin, Zhang Yin-Ling, Cao A-Yong, Li Da-Qiang

Kinesin-like protein KIFC2 stabilizes CDK4 to accelerate growth and confer resistance in HR+/HER2- breast cancer.

驱动蛋白样蛋白 KIFC2 可稳定 CDK4,从而加速 HR+/HER2- 乳腺癌的生长并赋予其耐药性

Yang Shao-Ying, Jin Ming-Liang, Andriani Lisa, Zhao Qian, Ling Yun-Xiao, Lin Cai-Jin, Huang Min-Ying, Cai Jia-Yang, Zhang Yin-Ling, Hu Xin, Shao Zhi-Ming, Zhang Fang-Lin, Jin Xi, Cao A Yong, Li Da-Qiang

Diagnostic implications of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammatory index for gastric carcinoma

中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值以及全身免疫炎症指数在胃癌诊断中的意义

Wu, Huang-Min; Ying, Xiao-Xuan; Lv, Li-Li; Hu, Jian-Wen

Self-Healing and Recyclable Polyurethane/Nanocellulose Elastomer Based on the Diels-Alder Reaction

基于狄尔斯-阿尔德反应的自修复可回收聚氨酯/纳米纤维素弹性体

Yang, Tao; Lin, Changhong; Huang, Min; Ying, Puyou; Zhang, Ping; Wu, Jianbo; Wang, Tianle; Kovalev, Alexander; Myshkin, Nikolai; Levchenko, Vladimir